Replies to post #279019 on Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

I agree Lemoncat, how can anyone say K is not viable? We all know that we need at least a completed FDA2b to give a good indication, and a 3 to be definitive; though we have good indications so far that it could be. Great results on K could get us to $5 yes, and even beyond, imo, but we all know the Iffy nature of that. I also think the IBD/IBS could result in great pps growth, but "could" is the word, as it is with B for OM. It's all kind of iffy, yes?

[kfcyahoo]

"Not so fast. I for one think it is our only hope of hitting $5."

Ha? The kevetrin architect(Menon) was put out to pasture. The CMO(Bertolino) just resigned. It appears that the company currently has, at most, two employees. An accountant and a clinical scientist. The latter, I suspect, may now be a consultant to the company(him).

They,or "we" as described in pr's, appear to have become him, or "I".
imho